about
Elevated blood harmane (1-methyl-9H-pyrido[3,4-b]indole) concentrations in essential tremorDietary factors in the etiology of Parkinson's disease.Blood harmane concentrations and dietary protein consumption in essential tremorQuantification of the neurotoxic beta-carboline harmane in barbecued/grilled meat samples and correlation with level of donenessCa(V)3.1 is a tremor rhythm pacemaker in the inferior oliveBlood harmane, blood lead, and severity of hand tremor: evidence of additive effects.Blood harmane (1-methyl-9H-pyrido[3,4-b]indole) concentrations in essential tremor: repeat observation in cases and controls in New YorkBlood harmane (1-methyl-9H-pyrido[3,4-b]indole) concentration in dystonia cases vs. controls.Harmine is a potent antimalarial targeting Hsp90 and synergizes with chloroquine and artemisininRelationship between blood harmane and harmine concentrations in familial essential tremor, sporadic essential tremor and controls.Mechanisms of DNA damage by photoexcited 9-methyl-β-carbolines.In vitro evaluation of β-carboline alkaloids as potential anti-Toxoplasma agents.Blood harmane concentrations in 497 individuals relative to coffee, cigarettes, and food consumption on the morning of testing.Comparative Effects of α-, β-, and γ-Carbolines on Platelet Aggregation and Lipid Membranes.Blood harmane (1-methyl-9H-pyrido[3,4-b]indole) concentration in essential tremor cases in Spain.Impact of tobacco regulation on animal research: new perspectives and opportunitiesHigher blood harmane (1-methyl-9H-pyrido[3,4-b]indole) concentrations correlate with lower olfactory scores in essential tremorGreater monoamine oxidase a binding in alcohol dependence.Environmental epidemiology of essential tremor.Elevated brain harmane (1-methyl-9H-pyrido[3,4-b]indole) in essential tremor cases vs. controls.Three-step synthesis of an annulated β-carboline via palladium catalysis.Elevated blood harmane (1-methyl-9H-pyrido[3,4-b]indole) concentrations in Parkinson's disease.Dietary inhibitors of monoamine oxidase A.Alkaloids in the human food chain--natural occurrence and possible adverse effects.Contribution of Monoamine Oxidase Inhibition to Tobacco Dependence: A Review of the Evidence.The Role of β-Carboline Alkaloids in the Pathogenesis of Essential Tremor.Behavioural studies on the ethanol leaf extract of Grewia carpinifolia in Wistar rats.Potent inhibition of human organic cation transporter 2 (hOCT2) by β-carboline alkaloids.Photosensitized electron transfer within a self-assembled norharmane-2'-deoxyadenosine 5'-monophosphate (dAMP) complex.Nicotine-, tobacco particulate matter- and methamphetamine-produced locomotor sensitisation in rats.Chemical and photochemical properties of chloroharmine derivatives in aqueous solutions.Impact of Precursors Creatine, Creatinine, and Glucose on the Formation of Heterocyclic Aromatic Amines in Grilled Patties of Various Animal Species.Tobacco particulate matter self-administration in rats: differential effects of tobacco type.Pharmacokinetic study of harmane and its 10 metabolites in rat after intravenous and oral administration by UPLC-ESI-MS/MS.Involvement of the cholinergic system of CA1 on harmane-induced amnesia in the step-down passive avoidance test.A rapid and simple method for the determination of psychoactive alkaloids by CE-UV: application to Peganum Harmala seed infusions.Selective Determination of Harmol by Room-Temperature Phosphorimetry: A Comparative Performance with Micellar Electrokinetic Capillary ChromatographyPharmaceutical Properties and Applications of a Natural Polymer from Grewia mollis
P2860
Q24656692-38EF4DD3-2E77-4CCF-B6F2-1669FA220029Q28085390-B8F87FCE-7EE1-4FC9-8057-00E913BE507EQ28266364-27102F41-6D76-4CE5-A39E-51923D0BFE5AQ28302011-5078C9B2-2F80-4088-8C2E-D1C767A6F259Q30495072-06C1F786-7106-441C-814C-088FC71BBE58Q34024964-CB34D8EB-1FA8-4ADA-B3D8-0361308BBA75Q34032624-78D4E123-D3CC-4116-9CBF-96BEA939C482Q34250523-AA5CFD6F-6B05-41FC-9861-88560B0EDCFEQ34276848-8FE2DC34-4AFE-45D8-997B-AFA731455A1BQ34279991-13F948A6-39BA-458B-A681-A42052F6AF6EQ34356691-DBE9730C-9A70-4FA7-8CDF-6F6FED8F21CFQ34714738-2497E490-DAC8-461D-B388-3557F798B8E6Q35102178-DA39B42E-43D4-4844-B089-6B49801FC57BQ35174205-8AF080BE-FCC3-46CF-9E75-7022893C9295Q36565922-3BB6D6AC-C076-4184-8354-281C29F4DE86Q36727831-C365990E-DDB2-4B78-8F51-DEC2DC7FFD0CQ36796439-0D7E007D-F84F-428B-887E-3B8A13DA47A9Q37088434-773C3D2F-4CE2-4CAC-8F9D-67FDA00402FFQ37196824-9B8178BB-FA66-4A39-A776-114536C8A818Q37200585-A31E1616-C8F9-4D89-9A29-B1A971CF9CC4Q37389310-9E78F639-AE57-48D3-A0D8-8696564A7CA3Q37559961-7ABC8F8E-660E-4B41-90FD-E2AEBD40C364Q37824443-C0DB6918-57F8-474E-8906-B7C2E4C7AF57Q37913264-B706396B-F680-4C96-B38E-C9B164F322EAQ38617975-D1CC6B2D-81EB-466E-8CA5-25A8F1B3DE21Q38658635-D5218F39-1C03-44AC-A2F1-7AD5F5BBDA73Q38860184-455D91D0-6351-414C-A506-B3D08BABA40CQ39098184-F9C36A45-87E8-4568-8561-1EEAFD348D03Q45945791-4E8CC874-3170-410A-936B-A8A37344166CQ46143485-EE820D2B-FEE3-47DC-AC28-34B32609806FQ46626596-ADA7B5E0-4AD3-4522-984E-4DE09CEBE581Q46658341-731A557F-2DFE-4F92-8BF3-04BB7199D335Q47777284-FB0693E7-C72B-45DF-9475-29D0DAD1E104Q48067071-2B1E14AE-6DC3-4C53-B708-7D750F70988DQ48107720-ECEB1FFA-836A-4481-9802-35F3E04D2793Q48175542-68D673DC-AD76-477B-B103-5180118475DBQ58273602-CD14AF8F-741D-40CD-9CB5-1A81396B1B65Q59021311-665AA997-2FD2-49CA-BBA2-77CDC7C16ADE
P2860
description
2004 nî lūn-bûn
@nan
2004 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի մարտին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Exposure to beta-carbolines norharman and harman.
@ast
Exposure to beta-carbolines norharman and harman.
@en
type
label
Exposure to beta-carbolines norharman and harman.
@ast
Exposure to beta-carbolines norharman and harman.
@en
prefLabel
Exposure to beta-carbolines norharman and harman.
@ast
Exposure to beta-carbolines norharman and harman.
@en
P1476
Exposure to beta-carbolines norharman and harman.
@en
P304
P356
10.1016/J.JCHROMB.2003.10.044
P577
2004-03-01T00:00:00Z